financetom
Business
financetom
/
Business
/
Dollar General cuts annual profit forecast on hurricane-related expenses
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Dollar General cuts annual profit forecast on hurricane-related expenses
Dec 5, 2024 4:43 AM

(Reuters) - Discount store operator Dollar General ( DG ) on Thursday trimmed the upper end of its annual profit forecast on hurricane-related expenses, while also laying out a plan to open more stores as well as remodel old ones next year.

The company said the updated forecast includes the impact of hurricane-related expenses of $32.7 million in the third quarter.

The dollar store chain operator also said it aims to open about 575 new stores in the U.S., while fully remodeling roughly 2,000 stores in the fiscal year ending January 2026.

The company expects annual earnings per share in the range of $5.50 to $5.90, compared with its prior forecast range of $5.50 to $6.20.

(Reporting by Anuja Bharat Mistry in Bengaluru; Editing by Sriraj Kalluvila)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Repare Therapeutics Shares Fall as Phase 1 Trial Results for Cancer Drugs Disappoint Investors
Repare Therapeutics Shares Fall as Phase 1 Trial Results for Cancer Drugs Disappoint Investors
Dec 12, 2024
05:53 PM EST, 12/12/2024 (MT Newswires) -- Repare Therapeutics ( RPTX ) shares fell 37% in after-hours trading Thursday as results from a phase 1 trial of cancer drugs disappointed investors. The combination of lunresertib and camonsertib achieved a 25.9% objective response rate in endometrial cancer and 37.5% in platinum-resistant ovarian cancer in the trial, the company said late Thursday...
Gilead appoints Sanofi official Dietmar Berger as next chief medical officer
Gilead appoints Sanofi official Dietmar Berger as next chief medical officer
Dec 12, 2024
(Reuters) - Gilead Sciences ( GILD ) said on Thursday it has appointed Sanofi's Dietmar Berger as its chief medical officer, replacing incumbent Merdad Parsey, who prepares to leave early next year. Berger, who will join on Jan. 2, is French pharmaceutical giant Sanofi's current chief medical officer. ...
Gilead Sciences Names Dietmar Berger as Chief Medical Officer
Gilead Sciences Names Dietmar Berger as Chief Medical Officer
Dec 12, 2024
05:53 PM EST, 12/12/2024 (MT Newswires) -- Gilead Sciences ( GILD ) said it appointed Dietmar Berger as its chief medical officer, effective Jan. 2, replacing Merdad Parsey. Berger brings over 25 years of experience in developing and delivering innovative medicines across a broad range of therapeutic areas, Gilead said late Thursday. He will also join Gilead's senior leadership team....
Mistras Group Names Hani Hammad as Chief Operating Officer
Mistras Group Names Hani Hammad as Chief Operating Officer
Dec 12, 2024
05:55 PM EST, 12/12/2024 (MT Newswires) -- Mistras Group ( MG ) said late Thursday it appointed Hani Hammad as chief operating officer, starting Jan.1. Hammad will continue his role as executive vice president, according to the company. Price: 9.09, Change: -0.01, Percent Change: -0.11 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved